Circulating citrullinated vimentin fragments reflect disease burden in ankylosing spondylitis and have prognostic capacity for radiographic progression

Arthritis and Rheumatism

Volumn 65, Issue 4, 2013, Pages 972-980

  Bay Jensen, Anne C ^a   Karsdal, Morten A ^a   Vassiliadis, Efstathios ^a   Wichuk, Stephanie ^b   Marcher Mikkelsen, Kathrine ^a   Lories, Rik ^c   Christiansen, Claus ^a   Maksymowych, Walter P ^b  

^a NORDIC BIOSCIENCE A S   (Denmark)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; MATRIX METALLOPROTEINASE; NONSTEROID ANTIINFLAMMATORY AGENT; VIMENTIN;

ADULT; AGE; ANKYLOSING SPONDYLITIS; ARTICLE; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ACTIVITY SCORE; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RADIOGRAPHY; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CITRULLINE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROLASES; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PEPTIDE FRAGMENTS; PROGNOSIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; ROC CURVE; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING; VIMENTIN; YOUNG ADULT;

EID: 84875715632     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.37843     Document Type: Article

References (34)

1. Karsdal MA, Delvin E, Christiansen C,. Protein fingerprints-relying on and understanding the information of serological protein measurements. Clin Biochem 2011; 44: 1278-9.
2. Karsdal MA, Henriksen K, Leeming DJ, Woodworth T, Vassiliadis E, Bay-Jensen AC,. Novel combinations of Post-Translational Modification (PTM) neo-epitopes provide tissue-specific biochemical markers-are they the cause or the consequence of the disease? Clin Biochem 2010; 43: 793-804.
3. Chapurlat RD, Garnero P, Breart G, Meunier PJ, Delmas PD,. Serum type I collagen breakdown product (serum CTX) predicts hip fracture risk in elderly women: the EPIDOS study. Bone 2000; 27: 283-6.
4. Qvist P, Christgau S, Pedersen BJ, Schlemmer A, Christiansen C,. Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting. Bone 2002; 31: 57-61.
5. Garnero P, Ferreras M, Karsdal MA, Nicamhlaoibh R, Risteli J, Borel O, et al. The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation. J Bone Miner Res 2003; 18: 859-67.
6. Qvist P, Bay-Jensen AC, Christiansen C, Sondergaard BC, Karsdal MA,. Molecular serum and urine marker repertoire supporting clinical research on joint diseases. Best Pract Res Clin Rheumatol 2011; 25: 859-72.
7. Vassiliadis E, Oliveira CP, Alvares-da-Silva MR, Zhang C, Carrilho FJ, Stefano JT, et al. Circulating levels of citrullinated and MMP-degraded vimentin (VICM) in liver fibrosis related pathology. Am J Transl Res 2012; 4: 403-14.
8. Ivaska J, Pallari HM, Nevo J, Erickson JE,. Novel functions of vimentin in cell adhesion, migration, and signaling. Exp Cell Res 2007; 313: 2050-62.
9. McInroy L, Maatta A,. Down-regulation of vimentin expression inhibits carcinoma cell migration and adhesion. Biochem Biophys Res Commun 2007; 360: 109-14.
10. Benes P, Maceckova V, Zdrahal Z, Konecna H, Zahradnickova E, Muzik J, et al. Role of vimentin in regulation of monocyte/macrophage differentiation. Differentiation 2006; 74: 265-76.
11. Mor-Vaknin N, Punturieri A, Sitwala K, Markovitz DM,. Vimentin is secreted by activated macrophages. Nat Cell Biol 2003; 5: 59-63.
12. Van Steendam K, Tilleman K, Deforce D,. The relevance of citrullinated vimentin in the production of antibodies against citrullinated proteins and the pathogenesis of rheumatoid arthritis. Rheumatology (Oxford) 2011; 50: 830-7.
13. Vossenaar ER, Radstake TR, van der Heijden A, van Mansum MA, Dieteren C, de Rooij DJ, et al. Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Ann Rheum Dis 2004; 63: 373-81.
14. Gyorgi B, Toth E, Tarcsa E, Falus A, Buzas EI,. Citrullination: a posttranslational modification in health and disease. Int J Biochem Cell Biol 2006; 38: 1662-77.
15. Tarcsa E, Marekov LN, Mei G, Melino G, Lee SC, Steinert PM,. Protein unfolding by peptidylarginine deiminase: substrate specificity and structural relationships of the natural substrates trichohyalin and filaggrin. J Biol Chem 1996; 271: 30709-16.
16. Alivernini S, Fedele AL, Cuoghi I, Tolusso B, Ferraccioli G,. Citrullination: the loss of tolerance and development of autoimmunity in rheumatoid arthritis. Reumatismo 2008; 60: 85-94.
17. Hochstrasser M,. Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. Curr Opin Cell Biol 1995; 7: 215-23.
18. Bang H, Egerer K, Gauliard A, Luthke K, Rudolph PE, Fredenhagen G, et al. Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis. Arthritis Rheum 2007; 56: 2503-11.
19. Besada E, Nikolaisen C, Nossent H,. Diagnostic value of antibodies against mutated citrullinated vimentin for rheumatoid arthritis. Clin Exp Rheumatol 2011; 29: 85-8.
20. Chapuy-Regaud S, Sebbag M, Baeten D, Clavel C, Foulquier C, De Keyser F, et al. Fibrin deimination in synovial tissue is not specific for rheumatoid arthritis but commonly occurs during synovitides. J Immunol 2005; 174: 5057-64.
21. Tilleman K, van Steendam K, Cantaert T, De Keyser F, Elewaut D, Deforce D,. Synovial detection and autoantibody reactivity of processed citrullinated isoforms of vimentin in inflammatory arthritides. Rheumatology (Oxford) 2008; 47: 597-604.
22. Green MJ, Gough AK, Devlin J, Smith J, Astin P, Taylor D, et al. Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis. Rheumatology (Oxford) 2003; 42: 83-8.
23. Maksymowych WP, Landewe R, Conner-Spady B, Dougados M, Mielants H, van der Tempel H, et al. Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis. Arthritis Rheum 2007; 56: 1846-53.
24. Van der Linden S, Valkenburg HA, Cats A,. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984; 27: 361-8.
25. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A,. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994; 21: 2286-91.
26. Creemers MC, Franssen MJ, van 't Hof MA, Gribnau FW, van de Putte LB, van Riel PL,. Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann Rheum Dis 2005; 64: 127-9.
27. Bay-Jensen AC, Leeming DJ, Kleyer A, Veidal SS, Schett G, Karsdal MA,. Ankylosing spondylitis is characterized by an increased turnover of several different metalloproteinase-derived collagen species: a cross-sectional study. Rheumatol Int 2012; 32: 3565-72.
28. Bay-Jensen AC, Liu Q, Byrjalsen I, Li Y, Wang J, Pedersen C, et al. Enzyme-linked immunosorbent assay (ELISAs) for metalloproteinase derived type II collagen neoepitope, CIIM-increased serum CIIM in subjects with severe radiographic osteoarthritis. Clin Biochem 2011; 44: 423-9.
29. Zhen EY, Brittain IJ, Laska DA, Mitchell PG, Sumer EU, Karsdal MA, et al. Characterization of metalloprotease cleavage products of human articular cartilage. Arthritis Rheum 2008; 58: 2420-31.
30. Gefter ML, Margulies DH, Scharff MD,. A simple method for polyethylene glycol-promoted hybridization of mouse myeloma cells. Somatic Cell Genet 1977; 3: 231-6.
31. Landewe R, van der Heijde D,. Radiographic progression depicted by probability plots: presenting data with optimal use of individual values. Arthritis Rheum 2004; 50: 699-706.
32. Davidson RK, Waters JG, Kevorkian L, Darrah C, Cooper A, Donell ST, et al. Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage. Arthritis Res Ther 2006; 8: R124.
33. Mattey DL, Dawson SR, Healey EL, Packham JC,. Relationship between smoking and patient-reported measures of disease outcome in ankylosing spondylitis. J Rheumatol 2011; 38: 2608-15.
34. Koivula MK, Aman S, Karjalainen A, Hakala M, Risteli J,. Are there autoantibodies reacting against citrullinated peptides derived from type I and type II collagens in patients with rheumatoid arthritis? Ann Rheum Dis 2005; 64: 1443-50.